Ototoxicity, Drug-Induced: Clinical Trials

7 trials for Ototoxicity, Drug-Induced, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 suspended. 2 Not applicable, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Not yet recruiting 1
Phase 22Recruiting 2
Early Phase 11Suspended 1

Follow Ototoxicity, Drug-Induced: new trials by email Literature Review of Ototoxicity, Drug-Induced trials Research Report on Ototoxicity, Drug-Induced

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Ototoxic Hearing Loss, Ototoxicity, Drug-Induced
RecruitingSimon Jäger552026-01-202026-10-20
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
ORC-13661, Placebo - Ototoxicity, Drug-Induced
Phase 2RecruitingKevin Winthrop1052025-06-022026-10-01
Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood
Audiogram - Ototoxicity, Drug-Induced, Ototoxicity, Radiation-Induced
Not applicableNot yet recruitingGustave Roussy, Cancer Campus, Grand Paris5002025-05-012025-05-04
Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial
Acetyl cysteine, Normal Saline - Cisplatin-induced Ototoxicity, Sensorineural Hearing Loss
Phase 2RecruitingSiriraj Hospital402024-12-232026-01-23
Diagnostic of Various Ototoxicity Induced by Cancer Treatment
Auditory, vestibular and electrophysiological investigations, Biologic investigations; seric proteins - Ototoxicity, Drug-Induced
RecruitingDirection Centrale du Service de Santé des Armées5402024-06-192024-07-08
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
Patients suffering from chemotherapy-induced ototoxicity, Patients suffring from chemotherapy-induced ototoxicity wearing hearing aids - Cancer, Ototoxicity, Drug-Induced
Not applicableActive not recruitingInstitut de Cancérologie de Lorraine522024-01-042026-10-22
Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
Sodium Thiosulfate - Ototoxicity, Drug-Induced
Early Phase 1SuspendedChildren's Hospital Medical Center, Cincinnati332023-03-012026-10-22

Narrower conditions

Ototoxicity (7)  ·  Hearing Loss (2)  ·  Hearing Loss, Sensorineural (2)  ·  Neoplasms (2)  ·  Deafness (1)  ·  Dizziness (1)  ·  Head and Neck Neoplasms (1)  ·  Hearing Disorders (1)  ·  Hepatoblastoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Vestibular Diseases (1)

Broader conditions

Chemically-Induced Disorders (7)  ·  Drug-Related Side Effects and Adverse Reactions (7)  ·  Ear Diseases (7)  ·  Otorhinolaryngologic Diseases (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Radiation Injuries (7)  ·  Wounds and Injuries (7)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Sensation Disorders (4)  ·  Signs and Symptoms (4)  ·  Hearing Disorders (3)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)

Interventions

Acetylcysteine (1)  ·  Audiometry (1)  ·  Cisplatin (1)  ·  ORC-13661 (1)  ·  Saline Solution (1)  ·  Vorinostat (1)  ·  sodium thiosulfate (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  Direction Centrale du Service de Santé des Armées (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Institut de Cancérologie de Lorraine (1)  ·  Kevin Winthrop (1)  ·  Simon Jäger (1)  ·  Siriraj Hospital (1)

Countries

France (3)  ·  United States (2)  ·  Germany (1)  ·  Thailand (1)

Top investigators

Brice Fresneau, MD, PhD (1)  ·  Edwin Rubel, PhD (1)  ·  Kanthong Thongyai, Master (1)  ·  Katherine Somers, MD (1)  ·  Kevin L Winthrop, MD, MPH (1)

NIH funding

U01DC020175 (1)